JPRN-UMIN000014765已完成未知
Investigation of the progression of atherosclerosis and atherosclerotic risk factor in patients with diabetes - Diabetes and progression of atherosclerosis and risk factor
Division of diabetes, Mitsui Memorial Hospital0 个研究点目标入组 700 人开始时间: 2014年8月6日最近更新:
适应症
试验速览
- 阶段
- 未知
- 状态
- 已完成
- 发起方
- 入组人数
- 700
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Observational
入排标准
- 年龄范围
- 45years-old 至 ot applicable（—）
- 性别
- All
入选标准
- 未提供
排除标准
- •1.post PCI and CABG 2.post implantation of peacemaker and ICD or CRT 3.cardiac shock 4.severe heart failure (more than NYHA3) 5.Cre more than1.5mg/dl 6.pheochromocytoma 7.bronchial asthma 8.Allergy of contrast agent 9.Severe thyroid disease 10.previous severe allergy to something 11.Pregnant, lactating, possibly pregnant or planning to become pregnant women 12.Malignant tumor 13.Patients considered as inadequate by the principal investigator
研究者
相似试验
尚未招募
不适用
Investigation of atherosclerotic formation mechanisms associating diurnal variation of blood glucose in patients with lifestyle-related diseaselifestyle-related disease and healthy volunteerJPRN-UMIN000014404Gunma University Hospital100
已完成
不适用
Prospective observational study of atherosclerosis progression in chronic kidney diseasechronic kidney diseaseJPRN-UMIN000015066Department of Nephrology and Hypertension, Internal Medicine, St. Marianna University School of Medi200
招募中
Unknown
An Exploratory Study of Atherosclerosis/Bleeding Risk Events in Patients Undergoing Percutaneous Coronary InterventioIschemic heart diseaseJPRN-UMIN000049264ihon University School of Medicine Department of Cardiology800
已完成
不适用
evaluation of atherosclerotic vascular lesions and terminal diseases as well as cardiovascular risk factors and experimental biomarkers in patients with primary sjögren-syndromeM35.0I70.9Sicca syndrome [Sjögren]Generalized and unspecified atherosclerosisDRKS00026261Medizinische Hochschule Hannover in Kooperation mit der Else-Kröner-Fresenius-Stiftung317
尚未招募
不适用
Analysis for regression of atherosclerosis in acute coronary syndrome patients after PCSK9 inhibitor therapy by using near-infrared spectroscopy and intravascular ultrasoundJPRN-UMIN000027238Kyoto Prefectural University of Medicine50